论文部分内容阅读
恶性肿瘤治疗进步依赖于针对新药或新方法的多中心Ⅲ期临床试验结果,下面分述2012年发表的恶性肿瘤治疗、筛查、预后和疗效监测临床研究的重要结果。一、化学治疗和靶向治疗1.培美曲塞联合卡铂治疗能延长体力状况不佳的晚期非小
Progress in the treatment of malignant tumors depends on the results of a multicentre Phase III trial of new drugs or new methods. The following is a review of the key findings from a 2012 clinical trial of malignant tumor therapy, screening, prognosis and efficacy monitoring. First, chemotherapy and targeted therapy 1. Pemetrexed combined with carboplatin can prolong the poor physical status of non-small late